167 related articles for article (PubMed ID: 1589989)
1. Adjuvant therapy for adenocarcinoma of the rectum.
O'Connell MJ; Gunderson LL
World J Surg; 1992; 16(3):510-5. PubMed ID: 1589989
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant therapy in rectal cancer: analysis of stage, sex, and local control--final report of intergroup 0114.
Tepper JE; O'Connell M; Niedzwiecki D; Hollis DR; Benson AB; Cummings B; Gunderson LL; Macdonald JS; Martenson JA; Mayer RJ
J Clin Oncol; 2002 Apr; 20(7):1744-50. PubMed ID: 11919230
[TBL] [Abstract][Full Text] [Related]
3. Large scale trial for adjuvant treatment in high risk resected colorectal cancers. Rationale to test the combination of loco-regional and systemic chemotherapy and to compare l-leucovorin + 5-FU to levamisole + 5-FU.
Rougier P; Nordlinger B
Ann Oncol; 1993; 4 Suppl 2():21-8. PubMed ID: 8353101
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
5. A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum: a progress report of National Surgical Breast and Bowel Project Protocol R-03.
Hyams DM; Mamounas EP; Petrelli N; Rockette H; Jones J; Wieand HS; Deutsch M; Wickerham L; Fisher B; Wolmark N
Dis Colon Rectum; 1997 Feb; 40(2):131-9. PubMed ID: 9075745
[TBL] [Abstract][Full Text] [Related]
6. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study.
Bosset JF; Calais G; Mineur L; Maingon P; Stojanovic-Rundic S; Bensadoun RJ; Bardet E; Beny A; Ollier JC; Bolla M; Marchal D; Van Laethem JL; Klein V; Giralt J; Clavère P; Glanzmann C; Cellier P; Collette L;
Lancet Oncol; 2014 Feb; 15(2):184-90. PubMed ID: 24440473
[TBL] [Abstract][Full Text] [Related]
7. Current status of adjuvant therapy for colorectal cancer.
O'Connell MJ
Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
[TBL] [Abstract][Full Text] [Related]
8. Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management.
Smith JJ; Chow OS; Gollub MJ; Nash GM; Temple LK; Weiser MR; Guillem JG; Paty PB; Avila K; Garcia-Aguilar J;
BMC Cancer; 2015 Oct; 15():767. PubMed ID: 26497495
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy for colon adenocarcinoma: current status of clinical investigation.
Köhne-Wömpner CH; Schöffski P; Schmoll HJ
Ann Oncol; 1994; 5 Suppl 3():97-104. PubMed ID: 8204538
[TBL] [Abstract][Full Text] [Related]
10. Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose.
Lee SH; Lee KC; Choi JH; Oh JH; Baek JH; Park SH; Shin DB
Jpn J Clin Oncol; 2008 Feb; 38(2):112-21. PubMed ID: 18263881
[TBL] [Abstract][Full Text] [Related]
11. Surgical adjuvant therapy of rectal cancer.
O'Connell MJ; Gunderson LL; Fleming TR
Semin Oncol; 1988 Apr; 15(2):138-45. PubMed ID: 3285477
[TBL] [Abstract][Full Text] [Related]
12. Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.
de Campos-Lobato LF; Stocchi L; da Luz Moreira A; Geisler D; Dietz DW; Lavery IC; Fazio VW; Kalady MF
Ann Surg Oncol; 2011 Jun; 18(6):1590-8. PubMed ID: 21207164
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience.
Thomas PR; Lindblad AS
Radiother Oncol; 1988 Dec; 13(4):245-52. PubMed ID: 3064191
[TBL] [Abstract][Full Text] [Related]
14. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
[TBL] [Abstract][Full Text] [Related]
15. Role of adjuvant therapy in surgically resected colorectal carcinoma.
Sinicrope FA; Sugarman SM
Gastroenterology; 1995 Sep; 109(3):984-93. PubMed ID: 7657129
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant treatment of colonic carcinoma].
Rochlitz CF; Herrmann R
Praxis (Bern 1994); 1995 Nov; 84(47):1373-6. PubMed ID: 7501918
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant treatment in operable stage II and III rectal cancer.
Aurelio P; Claudio C; Paolo M; Pierluigi G; Santina C; Domenico D; Numa C; Vincenzo V; Maurizio C; Fabrizio AI
Tumori; 1995; 81(3 Suppl):109-13. PubMed ID: 7571038
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant treatment of colorectal adenocarcinoma.
Steele G; Posner MR
Curr Probl Cancer; 1993; 17(4):223-69. PubMed ID: 8269716
[TBL] [Abstract][Full Text] [Related]
19. Low rectal cancer: impact of radiation and chemotherapy on surgical treatment.
Habr-Gama A; de Souza PM; Ribeiro U; Nadalin W; Gansl R; Sousa AH; Campos FG; Gama-Rodrigues J
Dis Colon Rectum; 1998 Sep; 41(9):1087-96. PubMed ID: 9749491
[TBL] [Abstract][Full Text] [Related]
20. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
